Asiamet Resources Limited

Declaration of Voting Results & Voting Rights Announcements • Jun 25, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4541S

Asiamet Resources Limited

25 June 2018

For Immediate Release                               London AIM

25 June 2018                                             Symbol: ARS

Results of AGM

Asiamet ("ARS" or the "Company") is pleased to announce that all resolutions proposed to shareholders at the Company's AGM held earlier today were duly passed.

Amongst other resolutions, all existing directors Peter Bird, Tony Manini, Peter Pollard, and Faldi Ismail were re-elected as directors of the Company. 

Also at the AGM, Ernst & Young LLP were appointed as the Company's auditors for the 2018 fiscal year, and the authorised share capital was increased to US$12,000,000 divided into 1,200,000,000 common shares of US$0.01 par value each.

ON BEHALF OF THE BOARD OF DIRECTORS

Peter Bird, Deputy Chairman and CEO

For further information, please contact:

-Ends-

Peter Bird

Deputy Chairman and CEO, Asiamet Resources Limited

Telephone: +61 3 8644 1300

Email: peter.bird@asiametresources.com

Tony Manini

Executive Chairman, Asiamet Resources Limited

Telephone: +61 3 8644 1300

Email: tony.manini@asiametresources.com

FlowComms Limited

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: [email protected]

Asiamet Resources Nominated Adviser

RFC Ambrian Limited

Andrew Thomson / Stephen Allen

Telephone: +61 8 9480 2500

Email: [email protected] / [email protected] 

Liberum

Neil Elliot, Clayton Bush, Kane Collings                

Telephone: +44 7773 322679

Email: [email protected]

Optiva Securities Limited

Christian Dennis

Telephone: +44 20 3137 1903

Email: [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RAGPGUMGQUPRUBA